JP2023522987A5 - - Google Patents

Info

Publication number
JP2023522987A5
JP2023522987A5 JP2022564247A JP2022564247A JP2023522987A5 JP 2023522987 A5 JP2023522987 A5 JP 2023522987A5 JP 2022564247 A JP2022564247 A JP 2022564247A JP 2022564247 A JP2022564247 A JP 2022564247A JP 2023522987 A5 JP2023522987 A5 JP 2023522987A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
bupivacaine
stable
free base
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022564247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028718 external-priority patent/WO2021216928A1/en
Publication of JP2023522987A publication Critical patent/JP2023522987A/ja
Priority to JP2024068119A priority Critical patent/JP2024091835A/ja
Publication of JP2023522987A5 publication Critical patent/JP2023522987A5/ja
Withdrawn legal-status Critical Current

Links

JP2022564247A 2020-04-22 2021-04-22 持続性ブピバカインマイクロスフェア製剤 Withdrawn JP2023522987A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024068119A JP2024091835A (ja) 2020-04-22 2024-04-19 持続性ブピバカインマイクロスフェア製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063013736P 2020-04-22 2020-04-22
US63/013,736 2020-04-22
PCT/US2021/028718 WO2021216928A1 (en) 2020-04-22 2021-04-22 Long-acting bupivacaine microsphere formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024068119A Division JP2024091835A (ja) 2020-04-22 2024-04-19 持続性ブピバカインマイクロスフェア製剤

Publications (2)

Publication Number Publication Date
JP2023522987A JP2023522987A (ja) 2023-06-01
JP2023522987A5 true JP2023522987A5 (https=) 2024-05-01

Family

ID=78270085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022564247A Withdrawn JP2023522987A (ja) 2020-04-22 2021-04-22 持続性ブピバカインマイクロスフェア製剤
JP2024068119A Pending JP2024091835A (ja) 2020-04-22 2024-04-19 持続性ブピバカインマイクロスフェア製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024068119A Pending JP2024091835A (ja) 2020-04-22 2024-04-19 持続性ブピバカインマイクロスフェア製剤

Country Status (5)

Country Link
US (1) US20240033221A1 (https=)
EP (1) EP4138783A4 (https=)
JP (2) JP2023522987A (https=)
CA (1) CA3180971A1 (https=)
WO (1) WO2021216928A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025015011A1 (en) * 2023-07-10 2025-01-16 Nevakar Injectables Inc. Bupivacaine compositions and methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
AU743024B2 (en) * 1997-03-05 2002-01-17 Sugen, Inc. Formulations for hydrophobic pharmaceutical agents
US6383168B1 (en) * 1998-12-08 2002-05-07 Bioject Medical Technologies Inc. Needleless syringe with prefilled cartridge
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
US9132085B2 (en) * 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
CN103827177B (zh) 2011-07-22 2016-02-10 伊诺科雷技术有限公司 用于生物活性化合物的受控释放的生物可降解的、半结晶的、相分离的、热塑性多嵌段共聚物
JP6422479B2 (ja) * 2013-03-15 2018-11-14 ハイプロテック、 インク． 複数チャンバ式の注射デバイス
US10449152B2 (en) * 2014-09-26 2019-10-22 Covidien Lp Drug loaded microspheres for post-operative chronic pain
KR102047983B1 (ko) * 2017-11-30 2019-11-22 주식회사 지투지바이오 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법
CA3110849A1 (en) * 2018-08-31 2020-03-05 Rilento Pharma, Llc Pharmaceutical formulation and system and method for delivery
WO2020071912A1 (en) 2018-10-02 2020-04-09 Innocore Technologies B.V. Extended release formulations of human chorionic gonadotropin (hcg)
JP7737981B2 (ja) 2019-10-01 2025-09-11 イノコア テクノロジーズ ホールディング ビー．ブイ． 生分解性の相分離した熱可塑性マルチブロックコポリマー

Similar Documents

Publication Publication Date Title
US20230091533A1 (en) Biodegradable drug delivery compositions
JP5951991B2 (ja) 医薬組成物
EP3655017B1 (en) Pharmaceutical composition
CN100566756C (zh) 含有分子量小于600道尔顿的聚乙二醇的药物组合物
US20180214507A1 (en) COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
BR9914258B1 (pt) Polímero triboloco biodegradável e composição polimérica aquosa biodegradável
JP2023522987A5 (https=)
JP2023522134A5 (https=)
JP2024091835A (ja) 持続性ブピバカインマイクロスフェア製剤
RU2789057C2 (ru) КОМПОЗИЦИИ И СПОСОБЫ ДЛИТЕЛЬНОГО ВЫСВОБОЖДЕНИЯ АНТАГОНИСТОВ ГОНАДОТРОПИН-ВЫСВОБОЖДАЮЩЕГО ГОРМОНА (GnRH)
EP2172189A1 (en) Pharmaceutical Compositions
HK40074403A (en) Compositions and methods for long term release of gonadotropin-releasing hormone (gnrh) antagonists
WO2021237039A1 (en) Compositions and methods for long term release of gonadotropin-releasing hormone (gnrh) antagonists
EP2213307A1 (en) Injectable depot formulations
HK1248146A1 (en) Biodegradable drug delivery compositions